Clinical Trial Update: Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a personalized mRNA neoantigen cancer vaccine in combination with anti-PD-1 inhibitors for gastrointestinal cancers in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Anti-PD-1 inhibitor (unspecified)
• Personalized neoantigen vaccine

Snippet

Sponsor: Ruijin Hospital | Conditions: Personalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant Therapy, Gastrointestinal Tumors | Phase 1 | Status: RECRUITING